India's own first drug - from Biocon.
...lab-to-market' molecule, Alzumab, to treat chronic plaque psoriasis at a cost 50 per cent lower than the ex...cal trial Genomics. The Biocon drug, at around ₹ 7,500 a vial, will cost half as much as the currently...3923 days ago